Corbus Pharmaceuticals I...

NASDAQ: CRBP · Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
After-hours: Aug 15, 2025, 04:56 PM EDT

Corbus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 881.71K
Cost of Revenue
n/a 31.17M 1.49M 1.64M
Gross Profit
n/a -31.17M -1.49M -757.53K
Operating Income
-48.72M -45.08M -39.84M -55.99M
Interest Income
6.31M n/a n/a 1.83K
Pretax Income
-40.21M -44.6M -42.35M -45.64M
Net Income
-40.21M -44.6M -55.83M -45.55M
Selling & General & Admin
16.5M 13.27M 18.7M 20.43M
Research & Development
32.22M 31.17M 16.14M 36.45M
Other Expenses
n/a -30.53M -48.77K 11.9M
Operating Expenses
48.72M 13.91M 34.84M 56.87M
Interest Expense
1.87M 2.92M 2.13M 1.83M
Selling & Marketing Expenses
n/a -641K n/a n/a
Cost & Expenses
n/a 45.08M 34.84M 56.87M
Income Tax Expense
n/a n/a n/a -87.84K
Shares Outstanding (Basic)
10.91M 4.33M 4.17M 4.1M
Shares Outstanding (Diluted)
10.91M 4.33M 4.17M 4.1M
EPS (Basic)
-3.68 -10.31 -13.39 -11.11
EPS (Diluted)
-3.68 -10.31 -13.39 -11.11
EBITDA
-37.74M -44.44M -38.73M -54.97M
EBIT
-38.34M -45.08M -40.21M -55.99M
Depreciation & Amortization
n/a 641K 1.49M 1.64M